Company News

04/27/2021

Dominion Energy Innovation Center Announces 2021 DEIC Accelerate Cohort

The Dominion Energy Innovation Center (“DEIC”) announced the eight startups that will make up the 2021 DEIC Accelerate cohort running from late May into September. “Clean energy products and technologies will benefit our communities and fast-track our endeavors to produce sustainable, green solutions,” said Senior Vice President and Chief Innovation Officer Mark Webb. “DEIC’s Accelerate

04/25/2021

Offices and Shared Lab Space Available at Virginia Bio+Tech Park

Office Space Available: Do you need a small office for your life science or advanced tech startup? The VA Bio+Tech Park in downtown Richmond has two offices available to fit 1-2 people. Find out more here or contact Heather.Allen@vabiotech.com. Shared Lab Space Available: Do you need to run a test but don’t have a dedicated lab? The VA

04/21/2021

NIH Awards Ceres Nanosciences $8.2M for Wastewater-Based COVID-19 Surveillance

Ceres Nanosciences announced it has been awarded an $8.2 million contract from the National Institutes of Health’s Rapid Acceleration of Diagnostics Initiative. The funding will support the development and implementation of wastewater-based surveillance systems for COVID-19. Manassas, Virginia-based Ceres plans to develop surveillance systems using its Nanotrap particle technology at a network of sites, with

04/21/2021

GRP Hires Mitchel Allen-Rivera as new Executive Vice President of Business Development

The Greater Richmond Partnership (“GRP”), the lead regional economic development organization serving the City of Richmond and counties of Chesterfield, Hanover and Henrico in Virginia, announces that Mitchel Allen-Rivera is the new Executive Vice President of Business Development. “I am thrilled to welcome Mitchel to Greater Richmond to lead business development,” said Jennifer Wakefield, President

04/21/2021

Novel small molecule technology reverses life-threatening opioid-induced respiratory depression

Case Western Reserve University and Atelerix Life Sciences Inc., a Charlottesville, Virginia-based biotechnology company, have signed a two-year option to license a novel family of small molecules called Active Thiol-Based Compounds (ATBC’s) to prevent or reverse life-threatening opioid-related side effects. The lead compound, ATLX–0199 (also called sudaxine), will be first targeted at opioid-induced respiratory depression

04/21/2021

HemoShear Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline

HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has identified a second drug target for the treatment of gout under its collaboration with Horizon Therapeutics plc (Nasdaq: HZNP) that was established in January 2019. Leveraging its proprietary REVEAL-TxTM disease modeling platform, HemoShear has earned two milestone payments to date in accordance with the